Cogent Biosciences, Inc. Common Stock (COGT) News

Latest headlines that mention COGT, newest first · each headline opens the original publisher

COGT quote

Last price: $29.52
Day change: +0.03%
Next earnings: 2026-11-06

Quote & chart Expected move Insider trading IV rank history

COGT headlines

latest coverage

Not much coverage yet. COGT has appeared in only a few headlines lately; new stories show up here as publishers cover it.

Investing.com 1mo ago

Cogent Biosciences director Arlene Morris sells $1.69m shares

General T3COGT

Seeking Alpha News 1mo ago

Cogent Biosciences: 3 NDAs Create A Time-To-Market Moat

General T2COGT

Investing.com 2mo ago

Cogent Biosciences set to report earnings ahead of FDA decisions

Earnings T3COGT

Seeking Alpha 2mo ago

Cogent Biosciences reports Q2 results

Earnings T2COGT

Yahoo Finance 3mo ago

Cogent Bioscience (COGT) Files New Drug Application For Bezuclastinib

General T2COGT

Yahoo Finance 3mo ago

Is Cogent Biosciences (COGT) ’s New Cancer Drug 100 Times More Precise Than What’s Already on the Market?

General T2COGT

Seeking Alpha News 4mo ago

Cogent Biosciences: A Pre-Commercial Biotech With Commercial-Stage Leverage

General T2COGT

Seeking Alpha News 4mo ago

Cogent Biosciences, Inc. (COGT) Presents at European Hematology Association (EHA) 2026 Congress - Slideshow

General T2COGT

Yahoo Finance 4mo ago

Is Cogent Biosciences, Inc. (COGT) A Good Stock To Buy Now?

General T2COGT

Investing.com 5mo ago

Form 13G Cogent Biosciences For: 14 May

General T3COGT

COGT news alerts

Get an alert by email or push when a new headline mentions COGT.

More news

News headlines aggregated from third-party publishers via public RSS feeds and tagged with the tickers they mention. Frenzy Capital does not publish or endorse the content; clicking a headline opens the original publisher in a new tab.